# US 6,730,499 B1 · Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,499 B1
- Document ID: US6730499B1
- Status: Granted
- Kind: B1
- Application number: 09/345,828
- Filed: 1999-07-02
- Granted: 2004-05-04
- Earliest claimed: 1998-07-03
- Assignees: Research Corporation Technologies, Inc.
- Inventors: James M. Cregg
- Web page: https://patentgrep.com/patent/US6730499B1

## CPC

- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 15/815: {for yeasts other than Saccharomyces}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides formaldehyde dehydrogenase genes (FLD) from methylotrophic yeasts. The FLD structural genes confer resistance to formaldehyde and are therefore useful as a selectable marker in methylotrophic yeasts. The FLD promoter sequences are strongly and independently induced by either methanol as sole carbon source (with ammonium sulfate as nitrogen source) or methylamine as sole nitrogen source (with glucose as carbon source). Induction under either methanol, methylamine or both provides levels of heterologous gene expression comparable to those obtained with the commonly used alcohol oxidase I gene promoter (PAOX1). The FLD promoter of Pichia pastoris (PFLD1)is an attractive alternative to PAOX1 for expression of foreign genes in P. pastoris, allowing regulation by carbon (methanol) or nitrogen (methylamine) source within the same expression strain. Yeast strains, expression cassettes, expression vectors, and host cells comprising an FLD gene promoter and 3′ termination sequence are also provided.

## Claims

### Claim 1

An expression cassette which comprises an isolated promoter sequence and a heterologous coding sequence, wherein said promoter sequence comprises the sequence as set forth in SEQ ID NO: 3 and is operably linked to the heterologous coding sequence.

### Claim 2 (depends on 1)

The expression cassette of claim 1 wherein the heterologous coding sequence encodes human serum albumin, invertase, bovine lysozyme, human EGF, mouse EGF, aprotinin, Kunitz protease inhibitor, Hepatitis B surface antigen, tumor necrosis factor, tetanus toxin fragment C, pertussis antigen P69, streptokinase, β-galactosidase, or Bacillus sp. crystal protein toxin.

### Claim 3 (depends on 1)

The expression cassette of claim 1 further comprising a 3′ termination sequence, wherein said 3′ termination sequence is operably linked to the 3′ end of said heterologous coding sequence.

### Claim 4 (depends on 3)

The expression cassette of claim 3, wherein said 3′ termination sequence is from an FLD gene of a methylotrophic yeast, and wherein said FLD gene comprises the coding sequence as set forth in SEQ ID NO: 5.

### Claim 5 (depends on 3)

The expression cassette of claim 3 wherein the 3′ termination sequence is that of the Pichia pastoris AOX1 gene, the Pichia pastoris p40 gene or the Pichia pastoris HIS4 gene.

### Claim 6 (depends on 1)

An expression vector which comprises an expression cassette according to claim 1.

### Claim 7 (depends on 3)

An expression vector which comprises an expression cassette according to claim 3.

### Claim 8 (depends on 4)

An expression vector which comprises an expression cassette according to claim 4.

### Claim 9 (depends on 5)

An expression vector which comprises an expression cassette according to claim 5.

### Claim 10 (depends on 1)

A host cell comprising an expression cassette according to claim 1.

### Claim 11 (depends on 3)

A host cell comprising an expression cassette according to claim 3.

### Claim 12 (depends on 4)

A host cell comprising an expression cassette according to claim 4.

### Claim 13 (depends on 5)

A host cell comprising an expression cassette according to claim 5.

### Claim 14 (depends on 6)

A host cell comprising an expression vector according to claim 6.

### Claim 15 (depends on 7)

A host cell comprising an expression vector according to claim 7.

### Claim 16 (depends on 8)

A host cell comprising an expression vector according to claim 8.

### Claim 17 (depends on 9)

A host cell comprising an expression vector according to claim 9.

### Claim 18 (depends on 14)

The host cell of claim 14 wherein said host cell is a methylotrophic yeast cell.

### Claim 19 (depends on 15)

The host cell of claim 15 wherein said host cell is a methylotrophic yeast cell.

### Claim 20 (depends on 16)

The host cell of claim 16 wherein said host cell is a methylotrophic yeast cell.

### Claim 21 (depends on 17)

The host cell of claim 17 wherein said host cell is a methylotrophic yeast cell.

### Claim 22 (depends on 18)

The host cell of claim 18 wherein the methylotrophic yeast cell is from the genus Pichia, Candida, Hansenula, or Torulopsis.

### Claim 23 (depends on 19)

The host cell of claim 19 wherein the methylotrophic yeast cell is from the genus Pichia, Candida, Hansenula, or Torulopsis.

### Claim 24 (depends on 20)

The host cell of claim 20 wherein the methylotrophic yeast cell is from the genus Pichia, Candida, Hansenula, or Torulopsis.

### Claim 25 (depends on 21)

The host cell of claim 21 wherein the methylotrophic yeast cell is from the genus Pichia, Candida, Hansenula, or Torulopsis.

### Claim 26

A method for directing expression of a heterologous coding sequence in a methylotrophic yeast which comprises:
a) introducing into a methylotrophic yeast cell an isolated nucleic acid comprising an isolated promoter sequence and said heterologous coding sequence, wherein said promoter sequence comprises the sequence as set forth in SEQ ID NO: 3 and is operably linked at its 3′ end to the 5′ end of the heterologous coding sequence, said heterologous coding sequence operably linked at its 3′ end to the 5′ end of a termination sequence which functions in methylotrophic yeast;
b) growing said methylotrophic yeast cell in a medium having a carbon source and a nitrogen source, and after the carbon or nitrogen source is depleted;
c) inducing expression of said heterologous coding sequence by addition of methanol or methylamine or both methanol and methylamine.

### Claim 27

A method for directing expression of a heterologous coding sequence in a methylotrophic yeast which comprises:
a) introducing into a methylotrophic yeast cell an isolated nucleic acid comprising an isolated promoter sequence and said heterologous coding sequence, wherein said promoter sequence comprises the sequence as set forth in SEQ ID NO: 3 and is operably linked at its 3′ end to the 5′ end of the heterologous coding sequence, said heterologous coding sequence operably linked at its 3′ end to the 5′ end of a termination sequence which functions in methylotrophic yeast;
b) growing said methylotrophic yeast cell in a medium having a carbon source and a nitrogen source, and after the carbon or nitrogen source is depleted;
c) inducing expression of said heterologous coding sequence by addition of formaldehyde, formate, or a methylated amine.

### Claim 28 (depends on 27)

The method of claim 27 wherein the methylated amine is choline.

### Claim 29

A kit which comprises:
a) an expression cassette comprising an isolated promoter sequence and a 3′ termination sequence which functions in a methylotrophic yeast, wherein said promoter sequence comprises the sequence as set forth in SEQ ID NO: 3, and wherein at least one restriction site is located between said promoter sequence and said 3′ termination sequence so that a heterologous coding sequence may be inserted and operably linked to said promoter sequence and said 3′ termination sequence; and
b) a vector which replicates in a methylotrophic yeast or which integrates into the genome of a methylotrophic yeast, said vector comprising a marker gene and one or more restriction sites for insertion of said expression cassette.

### Claim 30

An isolated promoter sequence, wherein said promoter sequence comprises the sequence as set forth in SEQ ID NO: 3.

### Claim 31 (depends on 26, 27)

The method according to claim 26 or 27, wherein said carbon source is selected from glycerol or glucose, and wherein said nitrogen source is selected from ammonium salt or ammonium hydroxide.
